Repeated observation of breast tumor subtypes in independent gene expression data sets
Thérese Sørlie, Robert John Tibshirani, Joel S. Parker et al. · Proceedings of the National Academy of Sciences · 2003
Characteristic patterns of gene expression measured by DNA microarrays have been used to classify tumors into clinically relevant subgroups. In this study, we have refined the previously defined subtypes of breast tumors that could be distinguished by their distinct patterns of gene expression. A total of 115 malignant breast tumors were analyzed by hierarchical clustering based on patterns of expression of 534 "intrinsic" genes and shown to subdivide into one basal-like, one ERBB2-overexpressing, two luminal-like, and one normal breast tissue-like subgroup. The genes used for classification were selected based on their similar expression levels between pairs of consecutive samples taken from the same tumor separated by 15 weeks of neoadjuvant treatment. Similar cluster analyses of two published, independent data sets representing different patient cohorts from different laboratories, uncovered some of the same breast cancer subtypes. In the one data set that included information on time to development of distant metastasis, subtypes were associated with significant differences in this clinical feature. By including a group of tumors from BRCA1 carriers in the analysis, we found that this genotype predisposes to the basal tumor subtype. Our results strongly support the idea that many of these breast tumor subtypes represent biologically distinct disease entities.
Cited by 5,429 works. doi:10.1073/pnas.0932692100 Open-access PDF
Authors
- Thérese Sørlie
- Robert John Tibshirani
- Joel S. Parker
- Trevor J. Hastie
- James Stephen Marron
- Andrew B. Nobel
- Shibing Deng
- Hilde Johnsen
- Robert Pesich
- Stephanie Beate Geisler
- János Demeter
- Charles M. Perou
- Per Eystein Lønning
- Patrick O. Brown
- Anne‐Lise Børresen‐Dale
- David Botstein
References
- Molecular portraits of human breast tumours
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
- Gene expression profiling predicts clinical outcome of breast cancer
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
- Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
- A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
- Gene-Expression Profiles in Hereditary Breast Cancer
- Ki67 expression in breast cancer
- Diagnosis of multiple cancer types by shrunken centroids of gene expression
- The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma